Eggplant cures cancer?
Updated: Nov 12, 2019
What I love about my work is seeing how science is catching up and looking at therapies and treatments that focus on eliminating the cause while minimising harm to the rest of the body. When it comes to skin cancers the majority are non melanoma, meaning they do not involve the melanocytes. Whereas melanoma is a rare and very aggressive form of skin cancer that involve specialised melanocyte skin cells that produce the protective skin-darkening pigment melanin that protects the skin from UV radiation. The focus of today's blog will be on the two most common non melanoma skin cancers basal cell carcinoma (BCC) and squamous cell cell carcinoma (SCC). Treatment of these non melanoma cancers have traditionally involved surgery, radiation therapy and photodynamic therapy.
I personally still remember as a little girl seeing my nan recover from several surgeries that were aimed at removing skin cancers on her nose. They were painful, repetitive and left her with visible damage and what seemed like to my kid self a very long time in treatment. In her memory, I am so eager to share with you the beneficial treatment option of CuradermBEC5 cream.
CuradermBEC5 cream contains the active ingredient, Solasodine Glycosides, derived from eggplant and a less well-known plant from Australasia, the Devil's Apple. These 2 types of flora come together and have proven to be effective on keratosis (sun spots) and even age spots, often removing them within days.
The main feature of CuradermBEC5 therapy over other therapies is the specificity towards cancer cells, which translates to low recurrences of the cancers and the impressive cosmetic outcomes. The cream's component of solasodine rhamnosides preferentially interacts with cancer cells only and not normal cells which subsequently cause apoptosis only in cancer cells. This phenomenon is due to identified and characterised specific receptors, found on cancer cells only, which bind and internalise the solasodine rhamnosides leading to interaction with lysosomes and mitochondria. Subsequently, these cells commit suicide (apoptosis).
So far the only flaw with CuradermBEC5 therapy is the duration of treatment period, which ranges from 2 weeks to 14 weeks, depending on the size and type of the skin cancer. However, the impressive cosmetic end results with CuradermBEC5 therapy far outweigh the inconvenience of the treatment duration period.
Therapy with CuradermBEC5 is self-titrating, treatment is only stopped after the entire lesion has been replaced with normal skin and this depends on the type, size and depth of the lesion on the skin. Hence small basal cell carcinoma lesions can take one week of treatment and large lesions may take up to 14 weeks treatment. CuradermBEC5 treatment is only stopped when complete clinical regression is observed. The treatments criteria has resulted in no recurrences for over 5 year's follow-up period.
I think this is super exciting for us all, as not only do we have a gentle naturally derived treatment for skin cancer we also have science looking to nature to help us overcome disease.
I look forward to seeing the accessibility of this product grow in Australia. Currently the product seems to be easily purchased online.
You can check out more at: http://www.curadermbec5.com